Posted on 12/1/16
Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding
PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company announced today that it has received net proceeds . . .
Posted on 12/1/16
What's Pfizer's Excuse for Not Buying Exelixis?
Exelixis Inc. (NASDAQ:EXEL) reported in October that its kidney cancer drug Cabometyx outperformed Pfizer Inc.'s (NYSE:PFE) top-selling Sutent in first-line advanced kidney cancer patients. Exelixis' management . . .
Posted on 12/1/16
Johnson & Johnson Throws Caution to the Wind With a Large Bid for Actelion
CEO ALEX GORSKY. IMAGE SOURCE: JOHNSON & JOHNSON.Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) is a trend setter in the sector. Anytime it makes a move, its . . .
Posted on 12/1/16
Gamma Medica Announces New Partnership with Leading Medical Facility, Einstein Medical Center Philadelphia
SALEM, N.H. & PHILADELPHIA--(BUSINESS WIRE)--Gamma Medica, a leader in molecular breast imaging (MBI) technology, today announced that Einstein Medical Center Philadelphia has committed to purchase Pennsylvania’s . . .
Posted on 11/30/16
Merck Boosts Dividend 2% And Has Several Key Growth Drivers
Merck (NYSE:MRK) recently increased its dividend by 2%. Its overall yield is above that of the S&P 500 Index, at 3.02%. The firm has paid a . . .
Posted on 11/30/16
J&J - Approaching Value Territory, But I Am Not Waiting
Johnson & Johnson (NYSE:JNJ) is approaching value territory, but I am not waiting. Given my investment horizon, I don't try to catch the last 5% downside . . .
Posted on 11/30/16
Nabriva Announces Terms of Rights Offering
VIENNA, Austria and KING OF PRUSSIA, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV) announced today the terms of its rights offering for . . .
Posted on 11/30/16
Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals
Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today it has completed its previously announced acquisition of Kolltan Pharmaceuticals, Inc
Posted on 11/30/16
Aethon Announces Billings Clinic as Newest MedEx Customer
PITTSBURGH--(BUSINESS WIRE)--Aethon is announcing that Billings Clinic has selected Aethon’s MedEx suite of products to help improve their inpatient pharmacy operations. MedEx provides hospital pharmacies chain-of-custody . . .
Posted on 11/29/16
Celgene Stock Split: Is the Biotech Ready to Split Again?
The biotechnology industry has been a huge growth engine for the stock market in recent years, and Celgene (NASDAQ:CELG) stands as one of the biggest players . . .
Posted on 11/29/16
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Are the Affordable Care Act's days numbered? According to the campaign talk of President-elect Donald Trump, it's just a matter of time before . . .
Posted on 11/28/16
ImMAGE Biotherapeutics Announces Positive Results from Animal Studies
ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced today that is has successfully completed animal trials. The company is harnessing the power of the immune . . .
Posted on 11/23/16
Bellerophon Therapeutics Announces $12 Million Public Offering
WARREN, N.J., Nov. 23, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the pricing of a public offering with expected . . .
Posted on 11/22/16
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Are the Affordable Care Act's days numbered? According to the campaign talk of President-elect Donald Trump, it's just a matter of time before . . .
Posted on 11/21/16
Johnson & Johnson Takes Aim at AbbVie
Johnson & Johnson (NYSE:JNJ) just submitted an application for FDA approval of guselkumab, a next-generation therapy that if approved, will compete head-to-head against AbbVie Inc.'s (NYSE:ABBV) . . .
Posted on 11/21/16
Teva Pharmaceutical - Now Easy To Swallow
Some stocks are expensive but work out well anyway due to exciting earnings growth. Other times the best way to make money is to simply buy . . .
Posted on 11/21/16
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
Celgene (NASDAQ:CELG) and Bristol-Myers Squibb (NYSE:BMY) have gained plenty of attention recently as great healthcare value plays. My colleague Sean Williams included both stocks in his . . .
Posted on 11/21/16
Is Pfizer Rethinking a Company Spin-Off?
IMAGE SOURCE: GETTY IMAGES.Pfizer's (NYSE:PFE) stock jumped last week based on a Reuters report that the company could be planning to unload its consumer health unit . . .
Posted on 11/21/16
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Medicare spends billions of dollars each year on prescription drugs. That's not surprising. What might be surprising, though, is how much the federal healthcare program spends . . .
Posted on 11/21/16
Utz Quality Foods Opens New Health & Wellness Center
HANOVER, Pa.--(BUSINESS WIRE)--UTZ® QUALITY FOODS, LLC. the U.S.’s largest privately held snack food brand, celebrates the opening of its new Utz® Health & Wellness Center, designed . . .
Posted on 11/21/16
Immunomedics Comments on Receipt of Director Nominations
MORRIS PLAINS, N.J., Nov. 18, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) confirmed that venBio Select Advisor LLC has submitted a notice of nomination of four . . .
Posted on 11/18/16
Johnson & Johnson Is Sitting On A Time Bomb
I recently warned you about the detrimental effect that high interest rates could have on the valuation of Johnson & Johnson (NYSE:JNJ), but here I'll focus . . .
Posted on 11/18/16
Aclaris Announces Pricing of Public Offering of Common Stock
MALVERN, Pa., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced the pricing of its underwritten public offering . . .
Posted on 11/17/16
Philadelphia Eagles, Jefferson, and Rothman Institute Announce Partnership Renewal
The eight-year extension will run through the 2023 seasonThe Philadelphia Eagles announced an eight-year contract extension with Thomas Jefferson University, including Jefferson Health and the Sidney . . .
Posted on 11/17/16
The Scariest Thing About Pfizer's Dividend
For Pfizer (NYSE:PFE) shareholders who have come to count on steady dividends, there's one frightening thing that jumps out at anyone who looks: the dividend payout . . .
Philadelphia
